132 related articles for article (PubMed ID: 1280507)
21. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis.
Nishiguchi S; Kuroki T; Ueda T; Fukuda K; Takeda T; Nakajima S; Shiomi S; Kobayashi K; Otani S; Hayashi N
Ann Intern Med; 1992 Jan; 116(1):21-5. PubMed ID: 1309200
[TBL] [Abstract][Full Text] [Related]
22. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
Yoshizawa H; Watanabe J
Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
[No Abstract] [Full Text] [Related]
23. Significance of HCV RIBA-2 indeterminate results in high-risk individuals: assessment by a new third-generation RIBA assay and PCR.
García-Samaniego J; Soriano V; Silva E; Enríquez A; Muñoz F; González-Lahoz J; Di Bisceglie A
Vox Sang; 1994; 66(2):148-9. PubMed ID: 7514325
[No Abstract] [Full Text] [Related]
24. Hepatitis C virus infection from blood and blood products.
van der Poel CL
FEMS Microbiol Rev; 1994 Jul; 14(3):241-6. PubMed ID: 7522022
[TBL] [Abstract][Full Text] [Related]
25. [Demonstrating antibodies against hepatitis C virus in transfusion practice. Viral Hepatitis Working Group of the Société Française de la Transfusion Sanguine].
Maisonneuve P; Noël L
Transfus Clin Biol; 1994; 1(5):397-400. PubMed ID: 7529098
[No Abstract] [Full Text] [Related]
26. Non-A, non-B hepatitis and the anti-HCV assay.
Barbara JA; Contreras M
Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260
[TBL] [Abstract][Full Text] [Related]
27. Testing for HCV markers.
Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission.
Watanabe M; Ohkoshi S; Tawaraya H; Miyajima T; Shimotohno K; Kamimura T; Asakura H
Transfusion; 1994 Feb; 34(2):125-9. PubMed ID: 7508643
[TBL] [Abstract][Full Text] [Related]
29. Transmission of HCV infection by RIBA indeterminate and positive blood units.
Kolho E; Naukkarinen R; Krusius T
Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012
[TBL] [Abstract][Full Text] [Related]
30. Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody.
Wang YJ; Lee SD; Hwang SJ; Chan CY; Chow MP; Lai ST; Lo KJ
Vox Sang; 1994; 67(2):187-90. PubMed ID: 7528456
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
Skaug K; Li H; Jonassen TO; Larsen J; Figenschau KJ
Vox Sang; 1993; 64(4):215-9. PubMed ID: 7685969
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial.
González A; Esteban JI; Madoz P; Viladomiu L; Genesca J; Muñiz E; Enríquez J; Torras X; Hernández JM; Quer J
Hepatology; 1995 Aug; 22(2):439-45. PubMed ID: 7635410
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of an anti-HCV core peptide ELISA.
Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus infection detected by antibody tests and the polymerase chain reaction as a cause of liver dysfunction in renal transplant recipients.
McCruden EA; Welch S; Batchelor B; Allison MC; Dow B; Follett EA; Mills PR; Briggs JD
J Med Virol; 1994 Feb; 42(2):158-63. PubMed ID: 7512612
[TBL] [Abstract][Full Text] [Related]
35. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
Bååth L; Widell A; Nordenfelt E
J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
[TBL] [Abstract][Full Text] [Related]
36. Early antihepatitis C virus response with second-generation C200/C22 ELISA.
van der Poel CL; Bresters D; Reesink HW; Plaisier AA; Schaasberg W; Leentvaar-Kuypers A; Choo QL; Quan S; Polito A; Houghton M
Vox Sang; 1992; 62(4):208-12. PubMed ID: 1322611
[TBL] [Abstract][Full Text] [Related]
37. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
Hitzler WE; Runkel S
Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
[TBL] [Abstract][Full Text] [Related]
38. Post-transfusion chronic hepatitis C in children.
Matsuoka S; Tatara K; Hayabuchi Y; Nii M; Mori K; Kuroda Y
J Paediatr Child Health; 1994 Dec; 30(6):544-6. PubMed ID: 7865272
[TBL] [Abstract][Full Text] [Related]
39. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
[TBL] [Abstract][Full Text] [Related]
40. A case of transfusion-acquired hepatitis C.
Wreghitt TG; Gandhi MK; Gray JJ; Blagdon J; Rankin A; Coates PB
Clin Lab Haematol; 1993; 15(2):141-4. PubMed ID: 7688679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
